Compare PAR & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PAR | YDES |
|---|---|---|
| Founded | 1968 | 2013 |
| Country | United States | Taiwan |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | |
| Sector | Miscellaneous | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 588.2M | 543.0M |
| IPO Year | 1995 | N/A |
| Metric | PAR | YDES |
|---|---|---|
| Price | $13.86 | $5.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $33.20 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 20.4K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $455,547,000.00 | N/A |
| Revenue This Year | $9.82 | N/A |
| Revenue Next Year | $11.27 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 30.16 | N/A |
| 52 Week Low | $11.59 | $4.73 |
| 52 Week High | $72.15 | $25.00 |
| Indicator | PAR | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 47.47 | 39.29 |
| Support Level | $12.47 | N/A |
| Resistance Level | $14.37 | $13.19 |
| Average True Range (ATR) | 0.75 | 0.39 |
| MACD | 0.18 | 0.08 |
| Stochastic Oscillator | 39.83 | 35.14 |
PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). Its product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.